Clover Health Investments Corp. [NASDAQ: CLOV] traded at a low on 02/16/21, posting a -4.88 loss after which it closed the day’ session at $11.49. The company report on February 17, 2021 that FILING DEADLINE–Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CLOV and IRTC.
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
iRhythm Technologies (IRTC) Class Period: August 4, 2020 and January 28, 2021Lead Plaintiff Motion Deadline: April 2, 2021SECURITIES FRAUD To learn more, visit https://kclasslaw.com/cases/securities/nasdaqgs-irtc/.
The results of the trading session contributed to over 17921214 shares changing hands. Over the past one week, the price volatility of Clover Health Investments Corp. stands at 7.34% while the volatility over the past one month is 8.78%.
The market cap for CLOV stock reached $4.62 billion, with 103.50 million shares outstanding and 86.68 million shares in the current float. Compared to the average trading volume of 13.68M shares, CLOV reached a trading volume of 17921214 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Clover Health Investments Corp. [CLOV]?
Citigroup have made an estimate for Clover Health Investments Corp. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 02, 2021. While these analysts kept the previous recommendation, JP Morgan raised their target price to Neutral. The new note on the price target was released on February 01, 2021, representing the official price target for Clover Health Investments Corp. stock.
The Average True Range (ATR) for Clover Health Investments Corp. is set at 1.21, with the Price to Sales ratio for CLOV stock in the period of the last 12 months amounting to 7.41. The Price to Book ratio for the last quarter was 1.49, with the Price to Cash per share for the same quarter was set at 0.00.
How has CLOV stock performed recently?
Clover Health Investments Corp. [CLOV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.11. With this latest performance, CLOV shares dropped by -17.99% in over the last four-week period, additionally plugging by 9.43% over the last 6 months.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLOV stock in for the last two-week period is set at 37.93, with the RSI for the last a single of trading hit 33.01, and the three-weeks RSI is set at 41.55 for Clover Health Investments Corp. [CLOV]. The present Moving Average for the last 50 days of trading for this stock 13.40, while it was recorded at 12.25 for the last single week of trading.
Clover Health Investments Corp. [CLOV]: Deeper insight into the fundamentals
Reflecting on the efficiency of the workforce at the company, Clover Health Investments Corp. [CLOV] managed to generate an average of -$4,408 per employee.Clover Health Investments Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.30 and a Current Ratio set at 0.30.
Earnings analysis for Clover Health Investments Corp. [CLOV]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLOV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Clover Health Investments Corp. go to 78.30%.
Insider trade positions for Clover Health Investments Corp. [CLOV]
There are presently around $222 million, or 33.10% of CLOV stock, in the hands of institutional investors. The top three institutional holders of CLOV stocks are: UBS OCONNOR LLC with ownership of 2,281,243, which is approximately -19.956% of the company’s market cap and around 0.30% of the total institutional ownership; SUSQUEHANNA INTERNATIONAL GROUP, LLP, holding 2,147,623 shares of the stock with an approximate value of $24.68 million in CLOV stocks shares; and GROUP ONE TRADING, L.P., currently with $22.01 million in CLOV stock with ownership of nearly New of the company’s market capitalization.
Positions in Clover Health Investments Corp. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 77 institutional holders increased their position in Clover Health Investments Corp. [NASDAQ:CLOV] by around 13,151,684 shares. Additionally, 78 investors decreased positions by around 45,098,575 shares, while 1 investors held positions by with 38,894,000 shares. The mentioned changes placed institutional holdings at 19,356,259 shares, according to the latest SEC report filing. CLOV stock had 65 new institutional investments in for a total of 10,978,726 shares, while 64 institutional investors sold positions of 31,660,689 shares during the same period.